Never-Before-Used Targeted Treatment For Atypical Chronic Neutrophilic Leukemia

A recent article in the New England Journal of Medicine describes genetic testing of a rare blood cancer called atypical chronic neutrophilic leukemia (CNL) that revealed a new mutation present in most patients with the disease. The mutation also serves as an Achilles heel, allowing doctors at the University of Colorado Cancer Center to prescribe a never-before-used, targeted treatment. The first patient treated describes his best snowboarding season ever. "I'm a crazy sports fan," says the patient. "I go 30 days a season... (Source: Health News from Medical News Today)

Source: http://www.medworm.com/index.php?rid=7322664&cid=u_0_26_f&fid=23292&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FHcRRW0kcvsU%2F261559.php

chiropody courses phlebotomy courses in toronto phlebotomy training oklahoma